Alzheimer's Disease
|
0.700 |
Biomarker
|
disease |
CTD_human |
We observed three new genome-wide significant nonsynonymous variants associated with Alzheimer's disease: a protective variant in PLCG2 (rs72824905: p.Pro522Arg, P = 5.38 × 10<sup>-10</sup>, odds ratio (OR) = 0.68, minor allele frequency (MAF)<sub>cases</sub> = 0.0059, MAF<sub>controls</sub> = 0.0093), a risk variant in ABI3 (rs616338: p.Ser209Phe, P = 4.56 × 10<sup>-10</sup>, OR = 1.43, MAF<sub>cases</sub> = 0.011, MAF<sub>controls</sub> = 0.008), and a new genome-wide significant variant in TREM2 (rs143332484: p.Arg62His, P = 1.55 × 10<sup>-14</sup>, OR = 1.67, MAF<sub>cases</sub> = 0.0143, MAF<sub>controls</sub> = 0.0089), a known susceptibility gene for Alzheimer's disease.
|
28714976 |
2017 |
Alzheimer's Disease
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Parkinsonism, movement disorders and genetics in frontotemporal dementia.
|
26891767 |
2016 |
Alzheimer's Disease
|
0.700 |
Biomarker
|
disease |
CTD_human |
Evidence of trem2 variant associated with triple risk of Alzheimer's disease.
|
24663666 |
2014 |
Dementia
|
0.700 |
Biomarker
|
disease |
CTD_human |
To our knowledge, this is the first report of mutations in TREM2 causing a pure dementia.
|
18546367 |
2008 |
Dementia
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2.
|
15883308 |
2005 |
Alzheimer's Disease
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Dementia
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation.
|
29142083 |
2017 |
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Neurodegeneration-associated mutant TREM2 proteins abortively cycle between the ER and ER-Golgi intermediate compartment.
|
28768830 |
2017 |
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Parkinsonism, movement disorders and genetics in frontotemporal dementia.
|
26891767 |
2016 |
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms.
|
27995897 |
2016 |
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Disease-Associated Mutations of TREM2 Alter the Processing of N-Linked Oligosaccharides in the Golgi Apparatus.
|
25615530 |
2015 |
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A practical approach to diagnosing adult onset leukodystrophies.
|
24357685 |
2014 |
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy (PLOSL): a new report of an Italian woman and review of the literature.
|
23399524 |
2013 |
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2.
|
15883308 |
2005 |
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
An Italian family affected by Nasu-Hakola disease with a novel genetic mutation in the TREM2 gene.
|
12754369 |
2003 |
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features.
|
12925681 |
2003 |
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype.
|
12080485 |
2002 |
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Familial Alzheimer Disease (FAD)
|
0.510 |
Biomarker
|
disease |
CTD_human |
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.
|
28714976 |
2017 |
Familial Alzheimer Disease (FAD)
|
0.510 |
Biomarker
|
disease |
CTD_human |
Evidence of trem2 variant associated with triple risk of Alzheimer's disease.
|
24663666 |
2014 |
Familial Alzheimer Disease (FAD)
|
0.510 |
GeneticVariation
|
disease |
ORPHANET |
TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease.
|
23380991 |
2013 |
Frontotemporal dementia
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Parkinsonism, movement disorders and genetics in frontotemporal dementia.
|
26891767 |
2016 |
Amyotrophic Lateral Sclerosis
|
0.500 |
SusceptibilityMutation
|
disease |
ORPHANET |
The TREM2 variant p.R47H was more common in patients with ALS than in the controls and is therefore a significant risk factor for ALS (odds ratio, 2.40; 95% CI, 1.29-4.15; P = 4.1×10-3).
|
24535663 |
2014 |
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
In Finnish and Japanese patients with PLOSL, DAP12 mutations predominate, whereas TREM2 is mutated more frequently elsewhere.
|
15883308 |
2005 |